BDBM179969 US9669095, 9
SMILES CC[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](N(C)C(=O)[C@@H](C)N(C)C1=O)C(C)(C)CN(C)C(=O)[C@@H](NC(=O)OC)C(C)C)C(C)C)C(=O)[C@H](C)CCCCCSc1nnnn1C
InChI Key InChIKey=AGCABOIDTXZITD-LIWLMONPSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 179969
TargetGenome polyprotein(Hepatitis C virus (HCV genotype 1a, isolate H))
Enanta Pharmaceuticals
US Patent
Enanta Pharmaceuticals
US Patent
Affinity DataEC50: 55nMT: 2°CAssay Description:Briefly, replicon cells are seeded at 7,000 cells per well in 90 ul DMEM (without phenol red, Invitrogen Cat. #31053-036) per well with 10% FCS, 1% n...More data for this Ligand-Target Pair